Geode Capital Management’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-478,208
| Closed | -$395K | – | 4487 |
|
2025
Q1 | $395K | Buy |
478,208
+16,940
| +4% | +$14K | ﹤0.01% | 3633 |
|
2024
Q4 | $438K | Buy |
461,268
+7,768
| +2% | +$7.38K | ﹤0.01% | 3641 |
|
2024
Q3 | $454K | Sell |
453,500
-5,788
| -1% | -$5.79K | ﹤0.01% | 3619 |
|
2024
Q2 | $570K | Buy |
459,288
+18,063
| +4% | +$22.4K | ﹤0.01% | 3523 |
|
2024
Q1 | $574K | Buy |
441,225
+12,703
| +3% | +$16.5K | ﹤0.01% | 3561 |
|
2023
Q4 | $536K | Buy |
428,522
+18,205
| +4% | +$22.8K | ﹤0.01% | 3590 |
|
2023
Q3 | $534K | Buy |
410,317
+11,605
| +3% | +$15.1K | ﹤0.01% | 3579 |
|
2023
Q2 | $686K | Sell |
398,712
-369,887
| -48% | -$636K | ﹤0.01% | 3502 |
|
2023
Q1 | $1.12M | Buy |
768,599
+26,087
| +4% | +$38.1K | ﹤0.01% | 3294 |
|
2022
Q4 | $1.2M | Buy |
742,512
+6,939
| +0.9% | +$11.2K | ﹤0.01% | 3268 |
|
2022
Q3 | $2.46M | Sell |
735,573
-11,409
| -2% | -$38.2K | ﹤0.01% | 3014 |
|
2022
Q2 | $2.72M | Buy |
746,982
+21,559
| +3% | +$78.5K | ﹤0.01% | 3008 |
|
2022
Q1 | $5.24M | Sell |
725,423
-3,725
| -0.5% | -$26.9K | ﹤0.01% | 2772 |
|
2021
Q4 | $9.91M | Buy |
729,148
+3,540
| +0.5% | +$48.1K | ﹤0.01% | 2455 |
|
2021
Q3 | $15.2M | Buy |
725,608
+254,585
| +54% | +$5.34M | ﹤0.01% | 2152 |
|
2021
Q2 | $11.3M | Buy |
471,023
+202,103
| +75% | +$4.84M | ﹤0.01% | 2378 |
|
2021
Q1 | $7.87M | Buy |
268,920
+17,278
| +7% | +$506K | ﹤0.01% | 2518 |
|
2020
Q4 | $7.52M | Buy |
+251,642
| New | +$7.52M | ﹤0.01% | 2349 |
|